Evidence map›Paper›PMID 40525921›Full record

ArticleInvestigative ophthalmology & visual science2025

Identifying Retinal Features Using a Self-Configuring CNN for Clinical Intervention.

Daniel S Kermany, Wesley Poon, Anaya Bawiskar, Natasha Nehra, Orhun Davarci, Glori Das, Matthew Vasquez, Shlomit Schaal, Raksha Raghunathan, Stephen T C Wong

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel S KermanyTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Wesley PoonTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Anaya BawiskarTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Natasha NehraTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Orhun DavarciTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Glori DasTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Matthew VasquezTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Shlomit SchaalDepartment of Ophthalmology, Houston Methodist Academic Institute, Houston, Texas, United States.
Raksha RaghunathanTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.
Stephen T C WongTranslational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston, Texas, United States.

Funding

DeepStroke+: An Advanced Mobile AI Diagnostic Tool for Fast and Precise Detection of Acute Strokes in Mobile Stroke Units, Emergency Rooms, and Telestroke TriageR01NS140292 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI Rajan Gadhia, STEPHEN TC WONG · 2025 to 2026
$1.2M
Advancing Thyroid Cancer Diagnostics with AI-enhanced Multimodal Optical HistopathologyR01CA288613 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI Xingde Li, STEPHEN TC WONG · 2025 to 2026
$1.1M
Optical Coherence Tomography (OCT)-Guided Ultrafast, Nonthermal Laser Microablation for Non-invasive Vitreoretinal SurgeryF31EY037177 · NEI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Daniel Shafiee Kermany · 2025 to 2026
$76k
NCI NIH HHS R01 CA288613NEI NIH HHS F31 EY037177NINDS NIH HHS R01 NS140292
6 · The paper itself

Abstract

Purpose: Retinal diseases are leading causes of blindness worldwide, necessitating accurate diagnosis and timely treatment. Optical coherence tomography (OCT) has become a universal imaging modality of the retina in the past 2 decades, aiding in the diagnosis of various retinal conditions. However, the scarcity of comprehensive, annotated OCT datasets, that are labor-intensive to assemble, has hindered the advancement of artificial intelligence (AI)-based diagnostic tools. Methods: To address the lack of annotated OCT segmentation datasets, we introduce OCTAVE, an extensive 3D OCT dataset with high-quality, pixel-level annotations for anatomic and pathological structures. Additionally, we provide similar annotations for four independent public 3D OCT datasets, enabling their use as external validation sets. To demonstrate the potential of this resource, we train a deep learning segmentation model using the self-configuring no-new-U-Net (nnU-Net) framework and evaluate its performance across all four external validation sets. Results: The OCTAVE dataset collected consists of 198 OCT volumes (3762 B-scans) used for training and 221 OCT volumes (4109 B-scans) for external validation. The trained deep learning model demonstrates clinically significant performance across all retinal structures and pathological features. Conclusions: We demonstrate robust segmentation performance and generalizability across independently collected datasets. OCTAVE bridges the gap in publicly available datasets, supporting the development of AI tools for precise disease detection, monitoring, and treatment guidance. This resource has the potential to improve clinical outcomes and advance AI-driven retinal disease management.

Indexed as

Deep LearningNeural Networks, ComputerRetinaRetinal DiseasesTomography, Optical CoherenceHumansImaging, Three-Dimensional

Identifiers

PMID40525921
PMCPMC12178434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.